Tue, Nov 26, 2024 11:22 AM
NTPC Green Energy shares may see a subdued listing on Wednesday
A Flip by Avya Verma
Shilpa Medicare on Tuesday, November 26, said the Subject Expert Committee (Haematology) has given its approval to conduct Phase III clinical trials for the Recombinant Human Albumin (rHA) 20%. Shilpa Medicare's Recombinant Human Albumin 20% (rHA) is derived from yeast and offers a highly purified, structurally and functionally equivalent alternative to human serum albumin, the company said.
Open Flip
Indian investors have poured more than $70 billion into local stocks in the first 10 months of the year, putting inflows on track to reach an annual record just as global funds are exiting. Retail investors, including non-residents, have bought almost $17 billion of local shares this year through October on the National Stock Exchange of India.
Open Flip
Reported Standalone quarterly numbers for AARCON FACILITIES are: Net Sales at Rs 0.23 crore in September 2024 up 162.12% from Rs. 0.09 crore in September 2023. Quarterly Net Profit at Rs. 0.16 crore in September 2024 up 541.83% from Rs. 0.03 crore in September 2023. EBITDA stands at Rs. 0.16 crore in September 2024 up 433.33% from Rs. 0.03 crore in September 2023.
Open Flip
